US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 6.620
  • -0.030-0.45%
Trading Mar 25 10:14 ET
110.72MMarket Cap-6.76P/E (TTM)

Coya Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-40.79%3.55M
-99.97%1.95K
0
3.43M
126.84K
6M
6M
0
0
0
Operating revenue
-40.79%3.55M
-99.97%1.95K
--0
--3.43M
--126.84K
--6M
--6M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.61%20.8M
-2.50%4.08M
24.87%4.45M
104.69%6.66M
93.44%5.61M
41.72%13.91M
108.98%4.19M
33.89%3.56M
-5.57%3.25M
70.56%2.9M
Selling and administrative expenses
13.43%8.89M
-10.07%2.14M
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
-General and administrative expense
13.43%8.89M
-10.07%2.14M
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
Research and development costs
96.71%11.89M
7.47%1.94M
39.67%2.22M
222.02%4.57M
156.81%3.16M
22.42%6.04M
64.19%1.8M
12.66%1.59M
-2.03%1.42M
25.84%1.23M
Depreciation amortization depletion
0.00%27.36K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
-Depreciation and amortization
0.00%27.36K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
Operating profit
-118.26%-17.25M
-324.79%-4.08M
-24.87%-4.45M
0.56%-3.24M
-89.06%-5.48M
19.45%-7.9M
190.60%1.82M
-33.89%-3.56M
5.57%-3.25M
-70.56%-2.9M
Net non-operating interest income expense
Other net income (expense)
157.86%1.65M
154.32%444.23K
201.83%428.87K
116.67%344.45K
163.45%431.09K
126.28%639.37K
115.82%174.67K
110.46%142.09K
377.60%158.97K
5,523.73%163.63K
Other non- operating income (expenses)
157.86%1.65M
154.32%444.23K
201.83%428.87K
116.67%344.45K
163.45%431.09K
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
Income before tax
-114.77%-15.6M
-282.73%-3.64M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Income tax
-199.51%-720.29K
723.85K
Net income
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Net income continuous Operations
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Minority interest income
Net income attributable to the parent company
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-86.29%-14.88M
-330.32%-2.92M
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
Basic earnings per share
-24.05%-0.98
-220.00%-0.18
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
Diluted earnings per share
-24.05%-0.98
-220.00%-0.18
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -40.79%3.55M-99.97%1.95K03.43M126.84K6M6M000
Operating revenue -40.79%3.55M-99.97%1.95K--0--3.43M--126.84K--6M--6M--0--0--0
Cost of revenue
Gross profit
Operating expense 49.61%20.8M-2.50%4.08M24.87%4.45M104.69%6.66M93.44%5.61M41.72%13.91M108.98%4.19M33.89%3.56M-5.57%3.25M70.56%2.9M
Selling and administrative expenses 13.43%8.89M-10.07%2.14M12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M
-General and administrative expense 13.43%8.89M-10.07%2.14M12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M
Research and development costs 96.71%11.89M7.47%1.94M39.67%2.22M222.02%4.57M156.81%3.16M22.42%6.04M64.19%1.8M12.66%1.59M-2.03%1.42M25.84%1.23M
Depreciation amortization depletion 0.00%27.36K0.00%6.84K0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K
-Depreciation and amortization 0.00%27.36K0.00%6.84K0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K
Operating profit -118.26%-17.25M-324.79%-4.08M-24.87%-4.45M0.56%-3.24M-89.06%-5.48M19.45%-7.9M190.60%1.82M-33.89%-3.56M5.57%-3.25M-70.56%-2.9M
Net non-operating interest income expense
Other net income (expense) 157.86%1.65M154.32%444.23K201.83%428.87K116.67%344.45K163.45%431.09K126.28%639.37K115.82%174.67K110.46%142.09K377.60%158.97K5,523.73%163.63K
Other non- operating income (expenses) 157.86%1.65M154.32%444.23K201.83%428.87K116.67%344.45K163.45%431.09K904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K
Income before tax -114.77%-15.6M-282.73%-3.64M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Income tax -199.51%-720.29K723.85K
Net income -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Net income continuous Operations -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Minority interest income
Net income attributable to the parent company -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -86.29%-14.88M-330.32%-2.92M-17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M
Basic earnings per share -24.05%-0.98-220.00%-0.1823.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28
Diluted earnings per share -24.05%-0.98-220.00%-0.1823.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More